• Revista médica de Chile · Oct 2021

    Case Reports

    [Treatment of Hodgkin disease relapse after allogeneic transplantation with nivolumab. Report of two cases].

    • Cristián Carvallo, Francisca Negrete, Romina Morales, Nataly Lobos, Marcos Rojas, Kathy Jara, Constanza Schüler, Martín Vidal, Nicolás Garnham, and Claudio Mosso.
    • Facultad de Medicina, Universidad Finis Terrae, Santiago, Chile.
    • Rev Med Chil. 2021 Oct 1; 149 (10): 1507-1511.

    AbstractHodgkin's Lymphoma has a very good prognosis. In the unusually refractory patients allogeneic transplantation offers a chance of cure. The so-called checkpoint inhibitors, such as Nivolumab can play a relevant role in this type of patients. Their side effects and usefulness after allogeneic transplantation are under investigation. Relapse after allogeneic transplantation has an extremely poor prognosis. We report two patients with refractory Hodgkin's lymphoma who relapsed after an allogeneic transplant and who were successfully treated with Nivolumab.

      Pubmed     Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…